Suppr超能文献

胆汁盐肝脏转运的调节。蛋白质合成抑制对胆汁盐排泄及其与肝表面膜组分结合的影响。

Regulation of hepatic transport of bile salt. Effect of protein synthesis inhibition on excretion of bile salts and their binding to liver surface membrane fractions.

作者信息

Gonzalez M C, Sutherland E, Simon F R

出版信息

J Clin Invest. 1979 Apr;63(4):684-94. doi: 10.1172/JCI109351.

Abstract

The overall transport of bile salts across the hepatocyte is characterized as a carrier-mediated process whose rate-limiting step is biliary secretion. Specific bile salt binding proteins have been identified in liver surface membrane fractions and were postulated to represent the initial interaction in bile salt translocation across both the sinusoidal and canalicular membranes. To test this hypothesis, cycloheximide was administered to rats to inhibit hepatic protein synthesis. 16 h after cycloheximide administration [14C]leucine incorporation into hepatic protein was inhibited by 93% at 1 h and 47% at 12 h. However, values of liver function tests were not increased, although serum albumin, serum alanine amino-transferase, and alkaline phosphatase were significantly decreased. Light and electron microscopy did not demonstrate necrosis or fat accumulation. The latter demonstrated minimal disorganization of rough endoplasmic reticulum and occasional lamellar whorls. 16 h after cycloheximide administration bile salt independent bile flow, basal bile salt excretion, and basal bile flow were unaltered, but the maximum bile salt transport capacity was reduced to 62% of control and 24 h later to 38%. Decreased bile salt transport was reversible, for it returned to control values after 48 h, when hepatic protein synthesis was also normal. Maximum bromosulfophthalein (BSP) transport, on the other hand, was reduced after 16 h to only 85% of control. Both bile salt and BPS maximum transport capacities decreased with time during inhibition of protein synthesis, apparently following first order kinetics. It was estimated that their half-lives are 20 h for bile salt transport and 55 h for BSP transport. These different turnover rates suggest that cycloheximide does not decrease active transport through generalized hepatic dysfunction or alteration of high energy sources possibly required for transport. The maximum number of [14C]cholic acid binding sites in liver surface membrane fractions was determined by an ultrafiltration assay. They were reduced to 68% of control after 16 h of cycloheximide and to 25% after 24 h. This reduction in the number of binding sites is apparently selective, for the activities of the liver surface membrane enzymes (Na+-K+)ATPase, Mg++-ATPase, and 5'-nucleotidase were not significantly changed. The associated alterations in bile salt transport and the maximum number of binding sites after cycloheximide administration suggests that these receptors may be the bile salt carriers.

摘要

胆盐跨肝细胞的整体转运被认为是一个载体介导的过程,其限速步骤是胆汁分泌。在肝表面膜组分中已鉴定出特异性胆盐结合蛋白,并推测其代表胆盐跨窦状隙膜和胆小管膜转运过程中的初始相互作用。为验证这一假说,给大鼠注射放线菌酮以抑制肝脏蛋白质合成。注射放线菌酮16小时后,[14C]亮氨酸掺入肝蛋白的量在1小时时被抑制了93%,在12小时时被抑制了47%。然而,肝功能测试值并未升高,尽管血清白蛋白、血清丙氨酸转氨酶和碱性磷酸酶显著降低。光镜和电镜检查均未显示坏死或脂肪堆积。电镜显示粗面内质网仅有轻微紊乱,偶尔可见板层小体。注射放线菌酮16小时后,胆盐非依赖性胆汁流量、基础胆盐排泄量和基础胆汁流量未改变,但最大胆盐转运能力降至对照值的62%,24小时后降至38%。胆盐转运减少是可逆的,因为在48小时后当肝脏蛋白质合成也恢复正常时,其又恢复到对照值。另一方面,最大溴磺酚酞(BSP)转运在16小时后降至对照值的85%。在蛋白质合成抑制期间,胆盐和BSP的最大转运能力均随时间下降,显然遵循一级动力学。据估计,它们的半衰期分别为胆盐转运20小时和BSP转运55小时。这些不同的周转率表明,放线菌酮并非通过一般性肝功能障碍或可能是转运所需的高能源改变来降低主动转运。通过超滤测定法确定肝表面膜组分中[14C]胆酸结合位点的最大数量。注射放线菌酮16小时后,其降至对照值的68%,24小时后降至25%。结合位点数量的这种减少显然具有选择性,因为肝表面膜酶(Na+-K+)ATP酶、Mg++-ATP酶和5'-核苷酸酶的活性未显著改变。放线菌酮给药后胆盐转运和结合位点最大数量的相关变化表明,这些受体可能是胆盐载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2d/372003/f1532811747c/jcinvest00676-0143-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验